MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients

Journal of Cystic Fibrosis

Volumn 11, Issue 1, 2012, Pages 59-62

  Fernández Olmos, Ana ^a   García Castillo, María ^a   Morosini, María Isabel ^a   Lamas, Adelaida ^a   Máiz, Luis ^a   Cantón, Rafael ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CSIC   (Spain)

Author keywords

Cystic fibrosis; MALDI TOF MS; Non fermenting isolates; Proteomic identification

Indexed keywords

DNA 16S;

ACHROMOBACTER; ACINETOBACTER; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BORDETELLA; BURKHOLDERIA CEPACIA; CHRYSEOBACTERIUM; CYSTIC FIBROSIS; DNA SEQUENCE; GRAM NEGATIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROBIOLOGICAL EXAMINATION; NONFERMENTING GRAM NEGATIVE BACTERIA; OCHROBACTRUM; PANDORAEA; RALSTONIA;

ACHROMOBACTER; ACTINOBACTERIA; BURKHOLDERIA CEPACIA; CHRYSEOBACTERIUM; CYSTIC FIBROSIS; GRAM-NEGATIVE AEROBIC BACTERIA; HUMANS; PROTEOMICS; PSEUDOMONAS; RALSTONIA PICKETTII; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84855908959     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.09.001     Document Type: Article

References (19)

1. Hauser A.R., Jain M., Bar-Meir M., McColley S.A. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev 2011, 24:29-70.
2. LiPuma J.J. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010, 23:299-323.
3. Bosshard P.P., Zbinden R., Abels S., Boddinghaus B., Altwegg M., Bottger E.C. 16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting gram-negative bacteria in the clinical laboratory. J Clin Microbiol 2006, 44:1359-1366.
4. Wellinghausen N., Kothe J., Wirths B., Sigge A., Poppert S. Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with Cystic Fibrosis. J Clin Microbiol 2005, 43:4070-4075.
5. Ferroni A., Sermet-Gaudelus I., Abachin E., Quesne G., Lenoir G., Berche P., et al. Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center. J Clin Microbiol 2002, 40:3793-3797.
6. Degand N., Carbonnelle E., Dauphin B., Beretti J.L., Le Bourgeois M., Sermet-Gaudelus I., et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol 2008, 46:3361-3367.
7. Mellmann A., Cloud J., Maier T., Keckevoet U., Ramminger I., Iwen P., et al. Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol 2008, 46:1946-1954.
8. Seng P., Drancourt M., Gouriet F., La Scola B., Fournier P.E., Rolain J.M., et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 2009, 49:543-551.
9. Kidd T.J., Ramsay K.A., Hu H.H., Bye P.T.P., Elkins M.R., Grimwood K., et al. Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients. J Clin Microbiol 2009, 47:1503-1509.
10. Valdezate S., Vindel A., Maiz L., Baquero F., Escobar H., Canton R. Persistence and variability of Stenotrophomonas maltophilia in cystic fibrosis patients, Madrid, 1991-1998. Emerg Infect Dis 2001, 7:113-122.
11. Hansen C.R., Pressler T., Nielsen K.G., Jensen P.O., Bjarnsholt T., Hoiby N. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros 2010, 9:51-58.
12. Drevinek P., Mahenthiralingam E. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect 2010, 16:821-830.
13. Biddick R., Spilker T., Martin A., LiPuma J.J. Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis. FEMS Microbiol Lett 2003, 228:57-62.
14. Hogardt M., Ulrich J., Riehn-Kopp H., Tummler B. EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates. J Clin Microbiol 2009, 47:3435-3438.
15. Turton J.F., Shah J., Ozongwu C., Pike R. Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: Evidence for emerging species. J Clin Microbiol 2010, 48:1445-1449.
16. Coenye T., Goris J., Spilker T., Vandamme P., LiPuma J.J. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp nov. J Clin Microbiol 2002, 40:2062-2069.
17. Bizzini A., Durussel C., Bille J., Greub G., Prod'hom G. Performance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory. J Clin Microbiol 2010, 48:1549-1554.
18. Saiman L., Siegel J. Cystic Fibrosis Fdn Consensus C. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient-transmission. Infect Control Hosp Epidemiol 2003, 24:S6-S52.
19. Kerem E., Conway S., Elborn S., Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005, 4:7-26.